These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 13697901)

  • 41. THE INFLUENCE OF DIETARY CALCIUM ON ABSORPTION OF IRON.
    APTE SV; VENKATACHALAM PS
    Indian J Med Res; 1964 Feb; 52():213-8. PubMed ID: 14128912
    [No Abstract]   [Full Text] [Related]  

  • 42. [Cardiac involvement in hemochromatosis].
    Janower S; Rosmorduc O; Cohen A
    Presse Med; 2007 Sep; 36(9 Pt 2):1301-12. PubMed ID: 17574380
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Deferoxamine-chelatable iron in hemochromatosis and other disorders of iron overload.
    Baldus WP; Fairbanks VF; Dickson ER; Baggenstoss AH
    Mayo Clin Proc; 1978 Mar; 53(3):157-65. PubMed ID: 628226
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Iron accumulation in the liver of male patients with Wilson's disease.
    Shiono Y; Wakusawa S; Hayashi H; Takikawa T; Yano M; Okada T; Mabuchi H; Kono S; Miyajima H
    Am J Gastroenterol; 2001 Nov; 96(11):3147-51. PubMed ID: 11721763
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Synthetic amino acid chelating agents and iron metabolism.
    RUBIN M; PRINCIOTTO JV
    Ann N Y Acad Sci; 1960 Aug; 88():450-9. PubMed ID: 13744363
    [No Abstract]   [Full Text] [Related]  

  • 46. Oral iron chelator deferasirox in the treatment of secondary hemochromatosis following bone marrow transplantation in a patient with severe aplastic anemia.
    Quarta A; Melpignano A; Quarta G
    Acta Haematol; 2011; 125(4):219-21. PubMed ID: 21266801
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Neonatal hemochromatosis: a case and review of the literature.
    Adams PC; Searle J
    Am J Gastroenterol; 1988 Apr; 83(4):422-5. PubMed ID: 3279760
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Diagnosis and management of hereditary hemochromatosis.
    Salgia RJ; Brown K
    Clin Liver Dis; 2015 Feb; 19(1):187-98. PubMed ID: 25454304
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Proceedings: Postmortal level of tissue iron in hemochromatosis and its correlation to iron storage myocardosis].
    Brandt G; Pesch HJ; Durst OE
    Z Kardiol; 1975; Suppl 2():102. PubMed ID: 1199315
    [No Abstract]   [Full Text] [Related]  

  • 50. [Differences in the pattern of iron accumulation in primary and secondary hemochromatosis. Diagnostic importance and clinical consequences].
    Düllmann J; Wulfhekel U
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1990; 117(3):413-7. PubMed ID: 1703111
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Proceedings: Measurement of iron store and its significance in patients with primary haemochromatosis.
    Singh AK
    Br J Haematol; 1974 Jun; 27(2):359. PubMed ID: 4846281
    [No Abstract]   [Full Text] [Related]  

  • 52. [Effect of desferrioxamine B and 2-(beta-aminoethoxy)cyclohexylaminetetraacetate in experimental hemochromatosis in rats and in primary hemochromatosis of man].
    Bohne F; Lessmann J
    Arzneimittelforschung; 1969 Jun; 19(6):944-7. PubMed ID: 5820039
    [No Abstract]   [Full Text] [Related]  

  • 53. THE RATE OF IRON ACCUMULATION IN IRON STORAGE DISEASE.
    CROSBY WH; CONRAD ME; WHEBY MS
    Blood; 1963 Oct; 22():429-40. PubMed ID: 14072571
    [No Abstract]   [Full Text] [Related]  

  • 54. Pathogenesis of hereditary hemochromatosis.
    Fleming RE; Britton RS; Waheed A; Sly WS; Bacon BR
    Clin Liver Dis; 2004 Nov; 8(4):755-73, vii. PubMed ID: 15464654
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Characterization of ferroptosis in murine models of hemochromatosis.
    Wang H; An P; Xie E; Wu Q; Fang X; Gao H; Zhang Z; Li Y; Wang X; Zhang J; Li G; Yang L; Liu W; Min J; Wang F
    Hepatology; 2017 Aug; 66(2):449-465. PubMed ID: 28195347
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Metal storage disorders: Wilson disease and hemochromatosis.
    Kanwar P; Kowdley KV
    Med Clin North Am; 2014 Jan; 98(1):87-102. PubMed ID: 24266916
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Genetic disorders affecting proteins of iron metabolism: clinical implications.
    Sheth S; Brittenham GM
    Annu Rev Med; 2000; 51():443-64. PubMed ID: 10774476
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Chelating agents in occupational pathology].
    MICHAUX P
    Alger Medicale; 1961 Oct; 65():789-802. PubMed ID: 14473389
    [No Abstract]   [Full Text] [Related]  

  • 59. Effect of medicinal calcium preparations upon iron utilization by experimental rats.
    MOTLAG DB; NATH MC
    Ann Biochem Exp Med; 1961 Feb; 21():47-50. PubMed ID: 13773179
    [No Abstract]   [Full Text] [Related]  

  • 60. Chelating agents in the prevention and treatment of occupational diseases.
    BRIEGER H
    Arch Environ Health; 1960 Sep; 1():271-7. PubMed ID: 13804399
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.